Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3273606
Max Phase: Preclinical
Molecular Formula: C45H70N12O12S2
Molecular Weight: 1035.26
Molecule Type: Protein
Associated Items:
ID: ALA3273606
Max Phase: Preclinical
Molecular Formula: C45H70N12O12S2
Molecular Weight: 1035.26
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C45H70N12O12S2/c1-5-24(4)37-44(68)51-28(12-13-34(47)59)40(64)54-32(21-35(48)60)41(65)52-29(45(69)57-16-6-7-33(57)43(67)55-30(19-23(2)3)39(63)50-22-36(49)61)15-18-71-70-17-14-27(46)38(62)53-31(42(66)56-37)20-25-8-10-26(58)11-9-25/h8-11,23-24,27-33,37,58H,5-7,12-22,46H2,1-4H3,(H2,47,59)(H2,48,60)(H2,49,61)(H,50,63)(H,51,68)(H,52,65)(H,53,62)(H,54,64)(H,55,67)(H,56,66)/t24-,27-,28-,29-,30-,31-,32-,33-,37-/m0/s1
Standard InChI Key: LYMTYPYAMGKBID-XTDTXPIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1035.26 | Molecular Weight (Monoisotopic): 1034.4678 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Smith CW, Ferger MF.. (1976) Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6., 19 (2): [PMID:1249804] [10.1021/jm00224a010] |
Source(1):